Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 1310265, 7 pages
https://doi.org/10.1155/2017/1310265
Review Article

Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets

1Department of Pathophysiology, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Iasi, Romania
2Gastroenterology Department, “Sf. Spiridon” County Clinical Emergency Hospital, University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Iasi, Romania
33rd Internal Medicine Clinic, “Sf. Spiridon” County Clinical Emergency Hospital, University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Iasi, Romania

Correspondence should be addressed to Manuela Ciocoiu; moc.oohay@3002uiocoicm

Received 29 December 2016; Revised 2 March 2017; Accepted 9 March 2017; Published 21 March 2017

Academic Editor: Christian Trummer

Copyright © 2017 Georgiana-Emmanuela Gilca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. CDC, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011, U.S. Department of Health and Human Services CfDCaP, Atlanta, Ga, USA, 2011.
  2. M. Bayeva, K. T. Sawicki, and H. Ardehali, “Taking diabetes to heart—deregulation of myocardial lipid metabolism in diabetic cardiomyopathy,” Journal of the American Heart Association, vol. 2, no. 6, Article ID e000433, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. From, C. L. Leibson, F. Bursi et al., “Diabetes in heart failure: prevalence and impact on outcome in the population,” American Journal of Medicine, vol. 119, no. 7, pp. 591–599, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Berry, M. Brett, K. Stevenson, J. J. V. McMurray, and J. Norrie, “Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure,” Heart, vol. 94, no. 3, pp. 296–304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Falcão-Pires and A. F. Leite-Moreira, “Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment,” Heart Failure Reviews, vol. 17, no. 3, pp. 325–344, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Yildirim, D. Akman, D. Catalucci, and B. Turan, “Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1,” Cell Biochemistry and Biophysics, vol. 67, no. 3, pp. 1397–1408, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Loncarevic, D. Trifunovic, I. Soldatovic, and B. Vujisic-Tesic, “Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study,” BMC Cardiovascular Disorders, vol. 16, no. 1, article 242, 2016. View at Publisher · View at Google Scholar
  8. B. Maisch, P. Alter, and S. Pankuweit, “Diabetic cardiomyopathy—fact or fiction?” Herz, vol. 36, no. 2, pp. 102–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Ernande, C. Bergerot, E. R. Rietzschel et al., “Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?” Journal of the American Society of Echocardiography, vol. 24, no. 11, pp. 1268–1275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Pattoneri, F. B. Sozzi, E. Catellani et al., “Myocardial involvement during the early course of type 2 diabetes mellitus: usefulness of Myocardial Performance Index,” Cardiovascular Ultrasound, vol. 6, article 27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. K. Chaudhary, G. K. Aneja, S. Shukla, and S. M. Razi, “Study on diastolic dysfunction in newly diagnosed type 2 diabetes mellitus and its correlation with glycosylated haemoglobin (HbA1C),” Journal of Clinical and Diagnostic Research, vol. 9, no. 8, pp. OC20–OC22, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Wolf, Y. Winhofer, M. Krssak et al., “Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 26, no. 5, pp. 387–392, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. R. V. Shah, S. A. Abbasi, and R. Y. Kwong, “Role of cardiac MRI in diabetes,” Current Cardiology Reports, vol. 16, no. 2, article 449, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. van der Leeuw, J. W. Beulens, S. van Dieren et al., “Novel biomarkers to improve the prediction of cardiovascular event risk in type 2 diabetes mellitus,” Journal of the American Heart Association, vol. 5, no. 6, Article ID e003048, 2016. View at Publisher · View at Google Scholar
  15. J. M. Pappachan, G. I. Varughese, R. Sriraman et al., “Diabetic cardiomyopathy: pathophysiology, diagnostic evaluation and management,” World Journal of Diabetes, vol. 4, no. 5, pp. 177–189, 2013. View at Google Scholar
  16. M. Furuhashi, R. Fucho, C. Z. Görgün, G. Tuncman, H. Cao, and G. S. Hotamisligil, “Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice,” Journal of Clinical Investigation, vol. 118, no. 7, pp. 2640–2650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Cao, K. Maeda, C. Z. Gorgun et al., “Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice,” Diabetes, vol. 55, no. 7, pp. 1915–1922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. E. Heyliger, A. L. Scarim, V. P. Eymer, K. A. Skau, and D. M. Powell, “Characteristics of the myocardial PM-FABP: effect of diabetes mellitus,” Molecular and Cellular Biochemistry, vol. 176, no. 1-2, pp. 281–286, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Bagheri, A. N. Qasim, N. N. Mehta et al., “Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus,” American Journal of Cardiology, vol. 106, no. 8, pp. 1118–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Avlas, R. Fallach, A. Shainberg, E. Porat, and E. Hochhauser, “Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility,” Antioxidants and Redox Signaling, vol. 15, no. 7, pp. 1895–1909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Pal, S. Dasgupta, R. Kundu et al., “Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance,” Nature Medicine, vol. 18, no. 8, pp. 1279–1285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. K. Jensen, T. M. Bartz, K. J. Mukamal et al., “Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study,” Diabetes Care, vol. 36, no. 5, pp. 1222–1228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Jialal, S. Devaraj, A. Bettaieb, F. Haj, and B. Adams-Huet, “Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome,” Atherosclerosis, vol. 241, no. 1, pp. 130–137, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Cohen, M. Waldman, N. G. Abraham et al., “Caloric restriction ameliorates cardiomyopathy in animal model of diabetes,” Experimental Cell Research, vol. 350, no. 1, pp. 147–153, 2017. View at Publisher · View at Google Scholar
  25. H. Noyan, O. El-Mounayri, R. Isserlin et al., “Cardioprotective signature of short-term caloric restriction,” PLoS ONE, vol. 10, no. 6, Article ID e0130658, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. L. E. León, S. Rani, M. Fernandez, M. Larico, and S. D. Calligaris, “Subclinical detection of diabetic cardiomyopathy with MicroRNAs: challenges and perspectives,” Journal of Diabetes Research, vol. 2016, Article ID 6143129, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Tang, J. Li, W. Huang et al., “Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts,” Cardiovascular Research, vol. 88, no. 3, pp. 424–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Hu, J. D. Klein, J. Du, and X. H. Wang, “Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency,” Endocrinology, vol. 149, no. 11, pp. 5384–5390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Li, W. Ma, G. Yue et al., “Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 102, pp. 53–60, 2017. View at Publisher · View at Google Scholar
  30. R. Guo, Y. Zhang, S. Turdi, and J. Ren, “Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1832, no. 8, pp. 1136–1148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Bhuiyan, J. S. Pattison, H. Osinska et al., “Enhanced autophagy ameliorates cardiac proteinopathy,” Journal of Clinical Investigation, vol. 123, no. 12, pp. 5284–5297, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Petrova, Y. Yamamoto, K. Muraki et al., “Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 10, pp. 1425–1431, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Jiang, W. Liu, J. Deng et al., “Polydatin protects cardiac function against burn injury by inhibiting sarcoplasmic reticulum Ca2+ leak by reducing oxidative modification of ryanodine receptors,” Free Radical Biology and Medicine, vol. 60, pp. 292–299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Yan, X. Luo, Y. Li et al., “Effects of advanced glycation end products on calcium handling in cardiomyocytes,” Cardiology, vol. 129, no. 2, pp. 75–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. M. Sung, S. M. Hamza, and J. R. B. Dyck, “Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets,” Antioxidants and Redox Signaling, vol. 22, no. 17, pp. 1606–1630, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. A. C. T. Ng, V. Delgado, M. Bertini et al., “Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus,” Circulation, vol. 122, no. 24, pp. 2538–2544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. R. A. Towner, N. Smith, D. Saunders et al., “In vivo targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice,” Free Radical Research, vol. 49, no. 9, pp. 1140–1146, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Miki, S. Yuda, H. Kouzu, and T. Miura, “Diabetic cardiomyopathy: pathophysiology and clinical features,” Heart Failure Reviews, vol. 18, no. 2, pp. 149–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Faria and S. J. Persaud, “Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential,” Pharmacology & Therapeutics, vol. 172, pp. 50–62, 2017. View at Publisher · View at Google Scholar
  40. S. Yilmaz, U. Canpolat, S. Aydogdu, and H. E. Abboud, “Diabetic cardiomyopathy; summary of 41 years,” Korean Circulation Journal, vol. 45, no. 4, pp. 266–272, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Thum, C. Gross, J. Fiedler et al., “MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts,” Nature, vol. 456, no. 7224, pp. 980–984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Tan, T. Ichikawa, J. Li et al., “Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo,” Diabetes, vol. 60, no. 2, pp. 625–633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Ebisuya, K. Kondoh, and E. Nishida, “The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity,” Journal of Cell Science, vol. 118, no. 14, pp. 2997–3002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. D. M. Yellon and S. M. Davidson, “Exosomes nanoparticles involved in cardioprotection?” Circulation Research, vol. 114, no. 2, pp. 325–332, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Westermeier, J. A. Riquelme, M. Pavez et al., “New molecular insights of insulin in diabetic cardiomyopathy,” Frontiers in Physiology, vol. 7, article 125, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. N. A. Garcia, J. Moncayo-Arlandi, P. Sepulveda, and A. Diez-Juan, “Cardiomyocyte exosomes regulate glycolytic flux in endothelium by direct transfer of GLUT transporters and glycolytic enzymes,” Cardiovascular Research, vol. 109, no. 3, pp. 397–408, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Di Mauro, M. Iafisco, N. Salvarani et al., “Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs,” Nanomedicine, vol. 11, no. 8, pp. 891–906, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Rusconi, P. Ceriotti, M. Miragoli et al., “Peptidomimetic targeting of Cavβ2 overcomes dysregulation of the L-type calcium channel density and recovers cardiac function,” Circulation, vol. 134, no. 7, pp. 534–546, 2016. View at Publisher · View at Google Scholar · View at Scopus